BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/8/2022 7:44:25 AM | Browse: 389 | Download: 1396
 |
Received |
|
2022-08-01 09:51 |
|
Peer-Review Started |
|
2022-08-01 09:51 |
|
First Decision by Editorial Office Director |
|
2022-08-21 10:26 |
|
Return for Revision |
|
2022-08-21 10:26 |
|
Revised |
|
2022-09-08 07:53 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-10-19 03:39 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-10-19 06:56 |
|
Articles in Press |
|
2022-10-19 06:56 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-10-25 06:57 |
|
Publish the Manuscript Online |
|
2022-11-08 07:44 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Hematology |
| Manuscript Type |
Observational Study |
| Article Title |
T-cell immunoglobulin mucin molecule-3, transformation growth factor β, and chemokine-12 and the prognostic status of diffuse large B-cell lymphoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hao Wu, Hui-Cong Sun and Gui-Fang Ouyang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Ningbo Science and Technology Program |
2019A6-10312 |
|
| Corresponding Author |
Gui-Fang Ouyang, MD, Chief Physician, Department of Hematology, Ningbo First Hospital, Ningbo Clinical Research Center for Hematologic Malignancies, No. 59 Liuting Street, Ningbo 315010, Zhejiang Province, China. oyguifangoy@163.com |
| Key Words |
T-cell immunoglobulin mucin molecule-3; Transforming growth factor β; Chemokine-12; Diffuse large B-cell lymphoma |
| Core Tip |
Diffuse large B-cell lymphoma (DLBCL) is a malignant tumor with a poor prognosis. T-cell immunoglobulin mucin molecule-3 (Tim-3), transforming growth factor β (TGF-β), and chemokine 12 (CXCL12) can affect the prognosis of solid tumors by participating in the tumor immune escape. Therefore, we analyzed the effects of Tim-3, TGF-β, and CXCL12 expression on DLBCL prognosis. The results suggest that Tim-3 positive, TGF-β positive, and CXCL12 positive are independent risk factors; therefore, they can be used to evaluate the efficacy and prognosis of DLBCL patients. |
| Publish Date |
2022-11-08 07:44 |
| Citation |
Wu H, Sun HC, Ouyang GF. T-cell immunoglobulin mucin molecule-3, transformation growth factor β, and chemokine-12 and the prognostic status of diffuse large B-cell lymphoma. World J Clin Cases 2022; 10(32): 11804-11811 |
| URL |
https://www.wjgnet.com/2307-8960/full/v10/i32/11804.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v10.i32.11804 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
